Vicor Corporation to Hold Third Quarter Earnings Conference Call and Webcast on October 22, 2024
ANDOVER, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: VICR) announced today it will hold its third quarter […]
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024
PORTLAND, Maine, Oct. 08, 2024 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company […]
T2 Biosystems to Host Business Update Call on October 10, 2024
LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens […]
Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit
SAN JOSE, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a […]
Hanmi Financial Corporation Announces Third Quarter 2024 Earnings and Conference Call Date
LOS ANGELES, Oct. 08, 2024 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, […]
HBT Financial, Inc. to Announce Third Quarter 2024 Financial Results on October 21, 2024
BLOOMINGTON, Ill., Oct. 08, 2024 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”), the holding […]
Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer
SALT LAKE CITY, Oct. 08, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and […]
AvidXchange Announces Timing of Its Third Quarter 2024 Financial Results Conference Call and Webcast
CHARLOTTE, N.C., Oct. 08, 2024 (GLOBE NEWSWIRE) — AvidXchange Holdings, Inc. (Nasdaq: AVDX), a leading provider of accounts payable (AP) […]
TC Energy announces pricing of cash tender offers
CALGARY, Alberta, Oct. 08, 2024 (GLOBE NEWSWIRE) — News Release – TC Energy Corporation (TSX, NYSE: TRP) (“TC Energy”) today […]
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the […]
